Lymphadenopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
Line 21: | Line 21: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Physical examination]] | [[Category:Physical examination]] | ||
Revision as of 22:35, 29 July 2020
Lymphadenopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphadenopathy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Lymphadenopathy epidemiology and demographics |
Risk calculators and risk factors for Lymphadenopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2] Raviteja Guddeti, M.B.B.S. [3]
Overview
The estimated incidence of lymphadenopathy in children in the United States ranges from 35%- 45%. It is more common in the pediatric population. Race and gender have no predilection in lymphadenopathy incidence.
Epidemiology and Demographics
Incidence
- The estimated incidence of lymphadenopathy among children in the United States ranges from 35%- 45%.[1]
Age
- Patients of all age groups may develop lymphadenopathy.
- Lymphadenopathy is more commonly observed among children.
Gender
- Lymphadenopathy affects men and women equally.
Race
- There is no racial predilection for lymphadenopathy.[1]